Effective management of dietary cholesterol may prevent metastasis in patients with prostate cancer
the ONA take:
New findings from researchers in Australia indicate dietary measures may prevent metastasis of prostate cancer. The study findings show that a high-cholesterol diet increased the spread of the disease to the lymph nodes, lungs, and bones. The researchers report that high cholesterol did not increase the size of the original tumor, but cholesterol drew two key proteins to the surface of the prostate cancer cell. This action disrupted cell function, making the cancer more aggressive and spreading it throughout the body.
Further research is seeking to find a way to block the effect of cholesterol, potentially leading to future treatments that could prevent prostate cancer metastasis. But more importantly, managing the disease may be achieved through working with patients to reduce cholesterol through dietary measures and existing cholesterol medication.
New findings from researchers in Australia indicate dietary measures may prevent metastasis of prostate cancer.
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- In HER2+ Breast Cancer, Higher TIL Levels Associated With Improved OS
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Costs, Complications Higher for Women Who Undergo Second Surgery After BCS
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Fluorescent Nanoparticles Represent Novel Detection Method of HER2 Expression
- Assessment of Stromal Features in DCIS Requires Robustness
- Profile of Tivantinib and its Potential in the Treatment of Hepatocellular Carcinoma: the evidence to date
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|